Ramon Amat

1.4k total citations
23 papers, 986 citations indexed

About

Ramon Amat is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ramon Amat has authored 23 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ramon Amat's work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Adipose Tissue and Metabolism (4 papers). Ramon Amat is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Adipose Tissue and Metabolism (4 papers). Ramon Amat collaborates with scholars based in Spain, United States and Palestinian Territory. Ramon Amat's co-authors include Francesc Villarroya, Marta Giralt, Robert P. Fisher, Stéphane Larochelle, Jasmina J. Allen, Kevan M. Shokat, Miriam Sansó, David L. Bentley, Kira Glover-Cutter and Chao Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Ramon Amat

22 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ramon Amat Spain	12	643	306	175	135	115	23	986
Peter L.J. de Keizer Netherlands	15	719 1.1×	147 0.5×	285 1.6×	38 0.3×	53 0.5×	24	1.1k
Vincenzo Castronovo Belgium	13	393 0.6×	261 0.9×	172 1.0×	57 0.4×	264 2.3×	27	1.0k
Su Myung Jung South Korea	15	451 0.7×	162 0.5×	234 1.3×	42 0.3×	35 0.3×	27	870
Jiangxue Wu China	19	777 1.2×	251 0.8×	56 0.3×	96 0.7×	86 0.7×	34	1.1k
Robert A. H. van de Ven United States	11	391 0.6×	139 0.5×	114 0.7×	32 0.2×	168 1.5×	11	666
Andrea J. Hartlerode United States	8	960 1.5×	317 1.0×	218 1.2×	29 0.2×	307 2.7×	11	1.3k
Franca Saccucci Italy	16	450 0.7×	182 0.6×	79 0.5×	43 0.3×	84 0.7×	39	955
Sharon Olijslagers United Kingdom	8	572 0.9×	128 0.4×	539 3.1×	68 0.5×	36 0.3×	9	1.1k
Xiangbin Zhang United States	10	1.2k 1.8×	286 0.9×	105 0.6×	47 0.3×	156 1.4×	12	1.5k
Guili Lian China	9	816 1.3×	109 0.4×	140 0.8×	29 0.2×	57 0.5×	11	1.2k

Countries citing papers authored by Ramon Amat

Since Specialization

Citations

This map shows the geographic impact of Ramon Amat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramon Amat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramon Amat more than expected).

Fields of papers citing papers by Ramon Amat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramon Amat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramon Amat. The network helps show where Ramon Amat may publish in the future.

Co-authorship network of co-authors of Ramon Amat

This figure shows the co-authorship network connecting the top 25 collaborators of Ramon Amat. A scholar is included among the top collaborators of Ramon Amat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramon Amat. Ramon Amat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bernatowicz, Kinga, Ramon Amat, Joan Frigola, et al.. (2025). Radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction. Journal for ImmunoTherapy of Cancer. 13(1). e009140–e009140. 9 indexed citations

Carbonell, Caterina, Joan Frigola, Núria Pardo, et al.. (2023). Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC. Molecular Oncology. 17(5). 779–791. 4 indexed citations

Valencia, Karmele, Álvaro Teijeira, Cristina Bértolo, et al.. (2022). DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity. The Journal of Experimental Medicine. 219(12). 7 indexed citations

Iranzo, Patricia, Ana Callejo, David García-Illescas, et al.. (2022). Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer. Frontiers in Medicine. 9. 875974–875974. 53 indexed citations

Frigola, Joan, Caterina Carbonell, Patricia Iranzo, et al.. (2022). High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC. Journal for ImmunoTherapy of Cancer. 10(4). e004197–e004197. 6 indexed citations

Cedrés, S., Patricia Iranzo, Ana Callejo, et al.. (2021). Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort. Scientific Reports. 11(1). 21357–21357. 10 indexed citations

Callejo, Ana, Joan Frigola, Patricia Iranzo, et al.. (2021). Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients. Cancers. 13(13). 3249–3249. 9 indexed citations

Serra, Selma A., Ramon Amat, Fanny Rubio-Moscardó, et al.. (2021). LRRC8A-containing chloride channel is crucial for cell volume recovery and survival under hypertonic conditions. Proceedings of the National Academy of Sciences. 118(23). 27 indexed citations

Iranzo, Patricia, Ana Callejo, Alejandro Navarro, et al.. (2020). Immune checkpoint inhibitors (ICI) response in metastatic non-small cell lung cancer (NSCLC) patients with WNT pathway mutations (APC/CTNNB1).. Journal of Clinical Oncology. 38(15_suppl). e15137–e15137. 1 indexed citations

10.

Frigola, Joan, Alejandro Navarro, Caterina Carbonell, et al.. (2020). Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer. Molecular Oncology. 15(4). 887–900. 27 indexed citations

11.

Felip, Enriqueta, Alejandro Navarro, Ana Callejo, et al.. (2019). Whole exome sequencing (WES) of non-small cell lung cancer (NSCLC) for tumor mutational burden (TMB) analysis and long-term benefit to immune checkpoint inhibitors (ICIs).. Journal of Clinical Oncology. 37(15_suppl). 9071–9071. 1 indexed citations

12.

Amat, Ramon, René Böttcher, François Le Dily, et al.. (2018). Rapid reversible changes in compartments and local chromatin organization revealed by hyperosmotic shock. Genome Research. 29(1). 18–28. 34 indexed citations

13.

Rodríguez‐Cuenca, Sergio, Stefania Carobbio, Gwendolyn Barceló‐Coblijn, et al.. (2018). P465L‐PPARγ mutation confers partial resistance to the hypolipidaemic action of fibrates. Diabetes Obesity and Metabolism. 20(10). 2339–2350. 4 indexed citations

14.

Amat, Ramon, Nicholas Kwiatkowski, Brian J. Abraham, et al.. (2017). Activation of the p53 Transcriptional Program Sensitizes Cancer Cells to Cdk7 Inhibitors. Cell Reports. 21(2). 467–481. 60 indexed citations

15.

Gubern, Albert, Manel Joaquin, Miriam Marqués, et al.. (2016). The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells. Molecular Cell. 64(1). 25–36. 71 indexed citations

16.

Larochelle, Stéphane, Ramon Amat, Kira Glover-Cutter, et al.. (2012). Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nature Structural & Molecular Biology. 19(11). 1108–1115. 300 indexed citations

17.

Wohlbold, Lara, Karl A. Merrick, Saurav De, et al.. (2012). Chemical Genetics Reveals a Specific Requirement for Cdk2 Activity in the DNA Damage Response and Identifies Nbs1 as a Cdk2 Substrate in Human Cells. PLoS Genetics. 8(8). e1002935–e1002935. 50 indexed citations

18.

Amat, Ramon & Lorraine J. Gudas. (2010). RARγ is required for correct deposition and removal of Suz12 and H2A.Z in embryonic stem cells. Journal of Cellular Physiology. 226(2). 293–298. 24 indexed citations

19.

Amat, Ramon, Anna Planavila, Shen Liang Chen, et al.. (2009). SIRT1 Controls the Transcription of the Peroxisome Proliferator-activated Receptor-γ Co-activator-1α (PGC-1α) Gene in Skeletal Muscle through the PGC-1α Autoregulatory Loop and Interaction with MyoD. Journal of Biological Chemistry. 284(33). 21872–21880. 182 indexed citations

20.

Amat, Ramon, Gemma Solanes, Marta Giralt, & Francesc Villarroya. (2007). SIRT1 Is Involved in Glucocorticoid-mediated Control of Uncoupling Protein-3 Gene Transcription. Journal of Biological Chemistry. 282(47). 34066–34076. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact